Compounds > riluzole

Page last updated: 2024-08-16

riluzole and homovanillic acid

riluzole has been researched along with homovanillic acid in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (33.33)	18.2507
2000's	4 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J	1
Boireau, A; Bordier, F; Doble, A; Dubédat, P; Durand, G; Meunier, M; Miquet, JM; Peny, C	1
Boireau, A; Doble, A; Dubédat, P; Meunier, M; Miquet, JM	1
Araki, T; Imai, Y; Matsubara, M; Muramatsu, Y; Tanaka, K	1
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kumagai, T; Matsubara, M; Tanaka, K	1

Other Studies

6 other study(ies) available for riluzole and homovanillic acid

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology, 2009, Volume: 5, Issue:10 Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection	2009
Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice. Neuroreport, 1994, Dec-20, Volume: 5, Issue:18 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Riluzole; Thiazoles	1994
Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo. Neuroreport, 1994, Oct-27, Volume: 5, Issue:16 Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Extracellular Space; Homovanillic Acid; Male; Parkinson Disease, Secondary; Rats; Riluzole; Thiazoles	1994
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Neuroscience letters, 2001, Oct-12, Volume: 312, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Glutamic Acid; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neostriatum; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Riluzole; Substantia Nigra; Tyrosine 3-Monooxygenase	2001
Neuroprotective effect of riluzole in MPTP-treated mice. Brain research, 2001, Nov-09, Volume: 918, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Glutamic Acid; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Riluzole; Substantia Nigra; Synaptic Transmission; Tyrosine 3-Monooxygenase	2001